Document is current
Any future updates will be listed below
-
Authors
Bänziger, Silas https://orcid.org/0000-0002-3342-8914
Weisshaar, Kimmo https://orcid.org/0000-0001-9566-2346
Arokoski, Reetta
Gerull, Sabine https://orcid.org/0000-0002-6612-4220
Halter, Jörg https://orcid.org/0000-0003-4304-1956
Rovó, Alicia https://orcid.org/0000-0002-7757-4753
Bargetzi, Mario https://orcid.org/0000-0002-2519-6754
Goede, Jeroen S. https://orcid.org/0000-0001-7054-0174
Senft, Yuliya
Valenta, Sabine https://orcid.org/0000-0002-5598-9579
Passweg, Jakob R. https://orcid.org/0000-0001-7092-3351
Drexler, Beatrice https://orcid.org/0000-0002-7046-0825
-
Funding
Funding for this research was provided by:
Universität Basel
ProPatient Foundation
Kaiku Health Ltd.
Novartis
University of Basel
- License Information
-
More Information
Article History
Received: 24 May 2022
Accepted: 12 October 2022
First Online: 3 November 2022
Declarations
:
: The study was approved by the local ethics committee (EKNZ Nr. 2019–01563) and registered under ClinicalTrials.gov (NCT04128943). All parts of the study were performed within the principles of the Declaration of Helsinki. Informed consent was obtained from all patients for being included in the study.
: RA is an employee of Kaiku Health Ltd. The other authors declare no competing interests.
